BE study of Venlafaxine XR capsules in fasting state [Study Per­for­mance]

posted by madhavaraob – 2010-07-14 13:49 (5829 d 01:38 ago) – Posting: # 5622
Views: 7,089

Dear all,

We are planning to conduct a BE study of Venlafaxine XR capsules for Brazil submission. US-FDA recommends to conduct Bioequivalence study of Venlafaxine XR capsules only in fed conditions because of safety issues in fasting state. I would like to know about the safety concerns when dosed in fasting conditions. Is it reliable to carry out BE study for the said drug in fasting conditions? Can anyone provide me any data on safety issues for justifying the non conductance of BE study in fasting state.

Thanking You in anticipation.

Regards,
Madhav Rao

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
260 visitors (0 registered, 260 guests [including 18 identified bots]).
Forum time: 15:28 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5